HealthExpress: Pharmaceuticals and More UK

The Effects of Rasagiline on Balance and Gait in Parkinson's Disease Patients

By Vincent Kingsworth 26 Jun 2023

Introduction to Rasagiline and Parkinson's Disease

As a blogger who has been researching and writing about Parkinson's disease, I have come across numerous treatment options aimed at improving the quality of life for those affected by this condition. One such treatment is Rasagiline, a medication that has shown promising results in managing some of the symptoms of Parkinson's disease, particularly issues with balance and gait. In this article, I will be discussing the impact of Rasagiline on these two critical aspects of mobility in Parkinson's patients and the potential benefits of incorporating this medication into their treatment plan.

Understanding Parkinson's Disease and its Effects on Balance and Gait

Parkinson's disease is a progressive neurodegenerative disorder characterized by the gradual loss of dopamine-producing neurons in the brain. Dopamine plays a crucial role in regulating motor functions such as movement, balance, and coordination. As a result, individuals with Parkinson's often experience a range of motor symptoms, including tremors, muscle stiffness, and slowness of movement.

Balance and gait disturbances are among the most debilitating symptoms of Parkinson's disease. These issues can significantly impact a person's ability to walk, maintain posture, and perform daily activities. Additionally, impaired balance and gait can lead to an increased risk of falls and injuries, further compromising the quality of life for those living with the disease.

How Rasagiline Works in the Treatment of Parkinson's Disease

Rasagiline is a type of medication called a monoamine oxidase-B (MAO-B) inhibitor. It works by blocking the action of the enzyme monoamine oxidase-B, which is responsible for breaking down dopamine in the brain. By inhibiting the activity of this enzyme, Rasagiline helps to increase the levels of dopamine in the brain, thereby improving motor function in Parkinson's patients.

While Rasagiline is often used as an adjunct therapy to other Parkinson's medications such as Levodopa, it has also shown promise as a standalone treatment, particularly in the early stages of the disease. The potential benefits of Rasagiline in managing Parkinson's symptoms make it an important medication to consider for those struggling with balance and gait issues.

Research on the Effects of Rasagiline on Balance and Gait

Several clinical studies have explored the effects of Rasagiline on balance and gait in patients with Parkinson's disease. One such study, published in the journal "Movement Disorders," found that Rasagiline significantly improved gait speed and stride length in Parkinson's patients compared to a placebo group. Furthermore, the study suggested that these improvements were maintained over a six-month period, indicating that Rasagiline may have long-term benefits for gait and balance in Parkinson's patients.

Another study, published in the journal "Parkinsonism & Related Disorders," found that Rasagiline improved balance and reduced the risk of falls in patients with Parkinson's disease. This study also demonstrated that the benefits of Rasagiline on balance and gait were more pronounced in patients with mild to moderate Parkinson's, suggesting that early intervention with this medication may be crucial for optimal results.

Rasagiline as Part of a Comprehensive Treatment Plan

While Rasagiline has shown promise in improving balance and gait in Parkinson's patients, it is essential to recognize that it is not a cure for the disease and should be considered as part of a comprehensive treatment plan. This plan may include other medications, physical therapy, occupational therapy, and lifestyle modifications aimed at improving overall function and quality of life for those living with Parkinson's.

Working closely with a healthcare team, including neurologists, movement disorder specialists, and therapists, can help patients and their families determine the best course of action for managing Parkinson's disease and addressing balance and gait issues.

Potential Side Effects and Precautions

As with any medication, it is essential to be aware of potential side effects and precautions associated with Rasagiline. Some common side effects of Rasagiline include headache, dizziness, joint pain, and indigestion. More severe side effects, although rare, can include hallucinations, severe skin reactions, and an increased risk of hypertension.

It is crucial to discuss any potential risks or concerns with your healthcare provider before starting Rasagiline, and to monitor for side effects during treatment. Additionally, it is important to inform your healthcare provider of any other medications you may be taking, as certain drug interactions may occur with Rasagiline.

Conclusion: The Potential Benefits of Rasagiline for Parkinson's Patients

In conclusion, Rasagiline is a promising medication for improving balance and gait in patients with Parkinson's disease. The research supports its use as part of a comprehensive treatment plan aimed at improving motor function and overall quality of life for those living with this debilitating condition. As always, it is essential to consult with a qualified healthcare professional to determine if Rasagiline is an appropriate option for you or your loved one based on individual needs and circumstances.

Tags: rasagiline parkinson's disease balance gait
  • June 26, 2023
  • Vincent Kingsworth
  • 18 Comments
  • Permalink

RESPONSES

Brittney Lopez
  • Brittney Lopez
  • June 27, 2023 AT 22:20

I've seen firsthand how Rasagiline helped my mom stay upright longer during walks. It's not magic, but it's one of the few things that gave her back a little dignity. Thank you for writing this - it's rare to see real stories behind the meds.

Keerthi Kumar
  • Keerthi Kumar
  • June 28, 2023 AT 17:39

In India, we don't always have access to these medications… but I’ve seen families ration them like gold. Rasagiline isn’t just a drug - it’s a lifeline. And yet, in rural clinics, doctors still prescribe Levodopa as the only option. We need equity in neurology too.

Dade Hughston
  • Dade Hughston
  • June 29, 2023 AT 15:21

I read this whole thing and honestly I think its just another pill push by big pharma they always make these studies look good but if you dig deep the side effects are way worse than the benefits like hallucinations and hypertension who wants that especially when you already have tremors and stiffness plus why are they always so vague about the sample sizes like 20 people in a study lol

Jim Peddle
  • Jim Peddle
  • June 30, 2023 AT 04:39

The study they cited from Movement Disorders? Methodologically flawed. Placebo group wasn't matched for disease duration. And the 'six-month maintenance' claim? That's not longitudinal data - it's a short-term fluke. This is how pseudoscience gets normalized.

S Love
  • S Love
  • July 1, 2023 AT 07:08

This is exactly the kind of balanced, evidence-based writing we need more of. Rasagiline isn’t a cure, but for many, it’s the difference between needing help to stand and walking to the mailbox alone. Physical therapy + this med = real progress. Don’t let the cynics scare you off.

Pritesh Mehta
  • Pritesh Mehta
  • July 1, 2023 AT 12:07

Western medicine always thinks it has all the answers. In Ayurveda, we’ve treated tremors and imbalance for millennia with herbs like Mucuna pruriens and yoga-based balance regimens. Rasagiline? A temporary Band-Aid. The real solution lies in holistic living - not chemical dependency.

Billy Tiger
  • Billy Tiger
  • July 1, 2023 AT 18:39

Rasagiline is just another tool the system uses to keep people docile while they wait for the real cure that never comes. They don't want you walking better they want you taking pills so you stay quiet and don't ask why your body is falling apart

Katie Ring
  • Katie Ring
  • July 2, 2023 AT 18:50

Balance isn't just physical. It's existential. When your body betrays you, the medication becomes a metaphor - a way to hold onto the self you thought you'd lost. Rasagiline doesn't fix dopamine. It lets you remember what it felt like to be whole.

Adarsha Foundation
  • Adarsha Foundation
  • July 3, 2023 AT 11:42

I appreciate the thoughtful overview. In my community, many elders avoid new meds due to fear or misinformation. This article could help bridge that gap. Maybe we can translate it into Hindi and Tamil for local clinics?

Alex Sherman
  • Alex Sherman
  • July 5, 2023 AT 02:05

You say 'consult a professional.' But what if your neurologist doesn't even know what MAO-B inhibitors are? Or worse - what if they're on a pharmaceutical kickback? This isn't medicine. It's a transaction.

Oliver Myers
  • Oliver Myers
  • July 6, 2023 AT 11:04

I just want to say thank you for writing this with so much care. My dad started Rasagiline last year, and the difference in his morning walks? Night and day. He’s not cured - but he’s smiling again. That’s worth more than any study.

John Concepcion
  • John Concepcion
  • July 8, 2023 AT 03:30

Oh wow another blog post pretending to be science. Did you get paid by Teva? Or did you just copy-paste the press release? This isn't journalism - it's a drug ad with footnotes.

Caitlin Stewart
  • Caitlin Stewart
  • July 8, 2023 AT 12:25

I work in rehab. We use Rasagiline with caution, but when it works - it’s quiet, subtle, and profound. Not a miracle. Just a margin of safety. One less fall. One more day independent. That’s the real win.

Emmalee Amthor
  • Emmalee Amthor
  • July 9, 2023 AT 18:36

I think people forget that gait isn't just about muscles - its about the brain's ability to predict movement. Rasagiline doesn't fix the brain, but it gives it a little more time to catch up. That's all we need.

Leslie Schnack
  • Leslie Schnack
  • July 9, 2023 AT 22:27

Has anyone looked at the long-term cognitive effects? I’ve read conflicting reports about memory changes with MAO-B inhibitors. Is that being monitored in these studies?

Saumyata Tiwari
  • Saumyata Tiwari
  • July 11, 2023 AT 20:03

Western medicine is so arrogant. They patent a molecule, slap a brand name on it, and act like they invented balance. We’ve had Kriya yoga for this. You can’t buy dignity with a prescription.

Anthony Tong
  • Anthony Tong
  • July 12, 2023 AT 08:12

The study sample sizes are statistically insignificant. The funding sources are undisclosed. The FDA warning on MAO-B inhibitors is buried in the appendix. This is not science. It’s propaganda.

Roy Scorer
  • Roy Scorer
  • July 12, 2023 AT 20:38

You talk about quality of life like it's a measurable metric. But what about the soul? What about the grief of watching someone lose their rhythm? No pill brings back the dance. No drug restores the walk you had at 30. This isn't treatment - it's grief management.

Write a comment

Categories

  • Medications (37)
  • Health and Wellness (35)
  • Pharmacy and Healthcare (12)
  • Health and Medicine (11)
  • Mental Health (5)
  • Women's Health (4)
  • Neurology (2)
  • Lifestyle (2)
  • Industry (1)
  • Parenting (1)

ARCHIVE

  • November 2025 (1)
  • October 2025 (30)
  • September 2025 (13)
  • August 2025 (8)
  • July 2025 (6)
  • June 2025 (1)
  • May 2025 (4)
  • April 2025 (3)
  • March 2025 (4)
  • February 2025 (1)
  • January 2025 (3)
  • October 2024 (2)

Menu

  • About HealthExpress
  • HealthExpress Terms of Service
  • Privacy Policy
  • GDPR Compliance Framework
  • Contact Us

© 2025. All rights reserved.